Laparoscopic electrocoagulation followed by danazol in subfertile women with endometriosis

Konstantinos A. Papathanasiou, Chryssoula Papageorgiou, Tryfon Tsalikis, S. Mantalenakis
In: Journal of Obstetrics and Gynaecology · 1996 · vol. 16(1) , pp. 48–49 · doi:10.3109/01443619609028386 · W2113035525
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Laparoscopic electrocoagulation followed by danazol treatment resulted in a 41% pregnancy rate within 8 months for subfertile women with mild to moderate endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

SummarySummaryTwenty-nine infertile women with mild or moderate endometriosis were treated by laparoscopic cauterisation and followed up for 8 months. All patients were treated with danazol for 6 months starting immediately after laparoscopy. None of them suffered any complication. Twelve women of the 29 (41 per cent) achieved a pregnancy within 8 months. This IS similar to the pregnancies achieved after open surgery or hormone treatment. Pregnancy occurs sooner after operation. Laparoscopic electrocoagulation is a safe, quick and effective alternative method for the treatment of mild or moderate endometriosis in infertile women compared to treatment with laparotomy and excision of the endometriotic foci.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-06T06:31:40.515551+00:00
License: CC0 · commercial use OK